Preferred Label : tafamidis;

MeSH note : may be effective in treating transthyretin amyloid polyneuropathy;

CISMeF synonym : FX 1006A; tafamidis meglumine;

MeSH hyponym : FX1006A; FX-1006A;

Is substance : O;

UNII : 8FG9H9D31J;

InChIKey : TXEIIPDJKFWEEC-UHFFFAOYSA-N;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
https://www.has-sante.fr/jcms/p_3212995/fr/vyndaqel
2020
false
false
false
France
tafamidis
treatment outcome
insurance, health, reimbursement
adult
Transthyretin cardiac amyloidosis
tafamidis meglumine
administration, oral
amyloid neuropathies, familial
evaluation of the transparency committee
tafamidis
benzoxazoles

---
https://www.has-sante.fr/jcms/p_3115172/fr/vyndaqel
2019
false
false
false
France
tafamidis
treatment outcome
insurance, health, reimbursement
tafamidis meglumine
amyloid neuropathies
administration, oral
orphan drug production
evaluation of the transparency committee
tafamidis
benzoxazoles

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/vyndaqel_11042012_synthese_ct11936.pdf
http://www.has-sante.fr/portail/jcms/c_1268796/vyndaqel-tafamidis-meglumine
2012
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
benzoxazoles
benzoxazoles
insurance, health, reimbursement
controlled clinical trials as topic
treatment outcome
rare diseases
orphan drug production
administration, oral
tafamidis meglumine
tafamidis meglumine
tafamidis
tafamidis
tafamidis
amyloid neuropathies, familial
neurologic manifestations
disease progression
ATTRV30M amyloidosis

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-05/vyndaqel_11042012_ct11936.pdf
http://www.has-sante.fr/portail/jcms/c_1247876/vyndaqel
2012
France
French
evaluation of the transparency committee
tafamidis meglumine
tafamidis
tafamidis
tafamidis meglumine
administration, oral
insurance, health, reimbursement
tafamidis
orphan drug production
adult
rare diseases
child
pregnancy
treatment outcome
clinical trials, phase iii as topic
clinical trials, phase ii as topic
risk management
prealbumin
amyloid neuropathies, familial
benzoxazoles
benzoxazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Vyndaqel
2011
false
United Kingdom
English
French
syndication feed
tafamidis
tafamidis
benzoxazoles
benzoxazoles
administration, oral
orphan drug production
drug approval
treatment outcome
adult
pregnancy
breast feeding
drug evaluation, preclinical
rare diseases
prealbumin
amyloid neuropathies, familial
tafamidis
tafamidis meglumine
tafamidis meglumine
package leaflet
drug evaluation
summary of product characteristics

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.